Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Fragile X Syndrome
NCT01254045Phase 2Completed
- Sponsor
- Stanford University
- Start
- Feb 2007
- Primary completion
- Nov 2009
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Fragile X syndrome (FXS), sponsored by Stanford University. Started Feb 2007; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Fragile X syndrome (FXS)
Beyond the preview
Go deeper on NCT01254045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254045.